Literature DB >> 9390641

Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells.

R S Fife1, B T Rougraff, C Proctor, G W Sledge.   

Abstract

Matrix metalloproteinases (MMPs) play a major role in the phenomena of growth, invasion, and metastasis of malignant disease. We studied the effects of doxycycline, a synthetic tetracycline that has been shown to suppress MMP activity in other solid tumors, on osteosarcoma (OSA) cell proliferation and MMP activity in vitro. OSA cells from 6 patients and from one established human tumor cell line (U2OS) (American Type Culture Collection) were cultured in the presence or absence of doxycycline. Doxycycline (10 microg/ml) suppressed OSA cell proliferation threefold to sevenfold in all cultures. MMP activity was assessed by gelatin zymography and was diminished by approximately 50% in all cultures. We examined the hypothesis that induction of apoptosis is one of the mechanisms by which doxycycline inhibits OSA cell proliferation. Ethidium bromide-stained gels of DNA from cells grown in the presence of 5 microg/ml and 10 microg/ml of doxycycline revealed laddering consistent with apoptosis after 24 hours in culture. The demonstration that doxycycline suppresses cell proliferation and MMP activity and induces apoptosis in human OSA cells in vitro suggests that this well-tolerated oral agent may be effective in the in vivo treatment of OSA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9390641     DOI: 10.1016/s0022-2143(97)90130-x

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  30 in total

1.  Effects of chemically modified tetracyclines (CMTs) in sensitive, multidrug resistant and apoptosis resistant leukaemia cell lines.

Authors:  M Tolomeo; S Grimaudo; S Milano; M La Rosa; V Ferlazzo; G Di Bella; C Barbera; D Simoni; P D'Agostino; E Cillari
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

Review 2.  Chemically modified non-antimicrobial tetracyclines are multifunctional drugs against advanced cancers.

Authors:  Bal L Lokeshwar
Journal:  Pharmacol Res       Date:  2010-11-18       Impact factor: 7.658

3.  Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells.

Authors:  Q Meng; J Xu; I D Goldberg; E M Rosen; R A Greenwald; S Fan
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Inhibition of the single downstream target BAG1 activates the latent apoptotic potential of MYC.

Authors:  Xiao-Yong Zhang; Harla K Pfeiffer; Hestia S Mellert; Timothy J Stanek; Robyn T Sussman; Alpana Kumari; Duonan Yu; Isidore Rigoutsos; Andrei Thomas-Tikhonenko; Hans E Seidel; Lewis A Chodosh; Graham Packham; Renato Baserga; Steven B McMahon
Journal:  Mol Cell Biol       Date:  2011-10-10       Impact factor: 4.272

5.  Activation of c-Jun N-terminal kinase is essential for mitochondrial membrane potential change and apoptosis induced by doxycycline in melanoma cells.

Authors:  Jiunn-Min Shieh; Tur-Fu Huang; Chi-Feng Hung; Kuan-Hsien Chou; Yih-Jeng Tsai; Wen-Bin Wu
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

6.  Comparison of doxycycline and minocycline in the inhibition of VEGF-induced smooth muscle cell migration.

Authors:  Jianhua S Yao; Fanxia Shen; William L Young; Guo-Yuan Yang
Journal:  Neurochem Int       Date:  2006-12-04       Impact factor: 3.921

Review 7.  Current management of aneurysmal bone cysts.

Authors:  Howard Y Park; Sara K Yang; William L Sheppard; Vishal Hegde; Stephen D Zoller; Scott D Nelson; Noah Federman; Nicholas M Bernthal
Journal:  Curr Rev Musculoskelet Med       Date:  2016-12

8.  High error rates in selenocysteine insertion in mammalian cells treated with the antibiotic doxycycline, chloramphenicol, or geneticin.

Authors:  Ryuta Tobe; Salvador Naranjo-Suarez; Robert A Everley; Bradley A Carlson; Anton A Turanov; Petra A Tsuji; Min-Hyuk Yoo; Steven P Gygi; Vadim N Gladyshev; Dolph L Hatfield
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

9.  Lowering the apoptotic threshold in colorectal cancer cells by targeting mitochondria.

Authors:  Kevin Sales; Jan-Willem Taanman; Sas Dijk; Marc Winslet; Jayesh Sagar
Journal:  Cancer Cell Int       Date:  2010-09-06       Impact factor: 5.722

10.  Percutaneous doxycycline treatment of aneurysmal bone cysts with low recurrence rate: a preliminary report.

Authors:  William E Shiels; Joel L Mayerson
Journal:  Clin Orthop Relat Res       Date:  2013-05-14       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.